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Abstract
Background: The relationship of spirometric values to other respiratory and functional parameters in advanced age is
not well studied. We assessed this relationship in elderly subjects with either good or poor spirometric parameters to
reveal whether different domains of lung function show comparable differences between the two groups.
Methods: Among subjects of the population-based KORA-Age cohort (n= 935, 65-90y; 51% male) two groups were
selected from either the lower (LED; n= 51) or the upper (UED; n= 72) end of the FEV1 distribution. All subjects did not
have a history of lung disease and were non-smokers at the time of the study. Measurements included spirometry, body
plethysmography, diffusing capacity for NO and CO, respiratory pump function and exhaled NO (FeNO). In addition, 6-min
walking distance as a functional overall measure, as well as telomere length of blood leukocytes and serum 8-
hydroxydeoxyguanosine (8-OHdG) as potential markers of overall biological ageing and stress were determined.
Results: In the majority of parameters, LED subjects showed significantly impaired values compared to UED subjects.
Differences in spirometric parameters, airway resistance and respiratory pump function ranged between 10% and more
than 90% in terms of predicted values. In contrast, volume-related CO and NO diffusing capacity showed differences
between groups of lower than 5%, while telomere length, 8-OHdG and FeNO were similar. This was reflected in the
differences in “functional age” as derived from prediction equations.
Conclusions: In elderly subjects without a history of lung disease differences in spirometric parameters were associated
with differences in other lung-mechanical parameters including body plethysmography but not with differences in
volume-corrected gas exchange measures. Thus, the concept of a general “lung age” as suggested by the widespread use
of this term in connection with spirometry should be considered with caution.
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Background
In advanced age, spirometric indices show a large inter-
individual variability within the general population even
after accounting for age and determinants like sex, height
and ethnicity, and for several parameters the coefficient of
variation even increases with age [1]. The relationship
between the functional indices as measured in the same
lung-healthy subjects has not been extensively studied.
This is of interest since low spirometric values are often
used as an indicator of a reduced functional state of the
whole respiratory system, particularly by deriving an esti-
mated “lung age” e.g. to support smoking cessation [2]. In
fact, however, it is unclear whether this notion is adequate
in the sense that various functional parameters of the lung
show low values. This would have to be expected with a
common process of biological aging or premature aging.
To answer this question a comparison of different
domains of parameters is needed. Ideally, this requires a
logitudinal analysis but at least the comparison of different
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functional domains should be possible in a sample of age-
matched elderly subjects.
We therefore investigated in subjects of advanced age
who were free of lung disease according to their clinical
history, whether various functional indices show parallel
differences indicative of a general state of the respiratory
system that could be related to aging. For this purpose
we analyzed the relationships between forced expiratory
volume in 1 s (FEV1), static lung volumes, airway
conductance, respiratory pump function, pulmonary gas
exchange, exhaled biomarkers, systemic oxidative stress
and cell-biological age, as well as general physical
capacity. The study population comprised two sub-
groups of the KORA-Age cohort who had been selected
based on their percent predicted values of FEV1 either
being at the upper or the lower end of the distribution.
Methods
Spirometry was performed in the KORA study center
(Augsburg, Germany) within the frame of the KORA-
Age study conducted in 2009–10 [3]. The study was ap-
proved by the Ethics Committee of the Bavarian Medical
Association, and its details have been described previ-
ously [4]. Briefly, in 935 individuals aged 65–90 years
from the Augsburg region spirometric measurements
were performed in line with ATS/ERS recommendations
[5], and 840 subjects gave their written consent to be
contacted to participate in the current sub-study, for
which 200 individuals were selected from the upper and
lower tails of the FEV1%pred distribution based on refer-
ence equations of the lung-healthy population of the
Augsburg region [4]. Subjects were further examined at
the University Hospital of the Ludwig-Maximilians-
Universität in Munich: 104 with high (upper end of
distribution, UED) and 96 with low (lower end of
distribution, LED) FEV1%pred. The examination focused
on the respiratory system but also covered biomarkers
and physical capacity. For the present analysis, current
smokers and subjects with symptoms of chronic bron-
chitis or a respiratory infection within 3 weeks prior to
examination were excluded. Non-smoking status was
defined via self-report; additionally an exhaled carbon
monoxide value of < 7 ppm was required [6]. These
criteria led to an analysis sample of n = 72 (69% of
total) in the upper and n = 51 (53%) in the lower
group.
A detailed description of the methods is given in
Additional file 1. According to current guidelines, the
following assessments were performed and parameters
obtained: spirometry (FEV1, FVC, expiratory flow rates)
[5], body plethysmography (airway conductance (Gaw),
specific airway conductance (sGaw), total lung capacity
(TLCpleth), intrathoracic gas volume (ITGV), residual
volume (RV)) [7, 8], determination of CO and NO
uptake of the lung (transfer factors TLCO, TLNO, trans-
fer coefficients KCO, KNO; alveolar volume (VA), TLC
by helium dilution (TLCHe)) [9], measurements of
mouth occlusion pressure (0.1 s after the onset of tidal
inspiration (P01), peak maximal static inspiratory mouth
occlusion pressure (PImax)) [10], exhaled carbon mon-
oxide (eCO) and exhaled nitric oxide at 50 ml/s (FeNO)
[11]. Furthermore, a 6-min walk test was performed
[12]. The telomere length of circulating leukocytes
[13] and the serum level of 8-hydroxydeoxyguanosine
(8-OHdG) were assessed from samples collected in
the KORA study centre in Augsburg.
Data analysis
Group comparisons were performed as Student’s t-test if
not stated otherwise. The robustness of results was
tested with analysis of covariance (ANCOVA) and differ-
ent confounders. Similarly, the associations of the func-
tional indices with telomere length or 8-OHdG were
examined using multiple linear regression analysis, with
chronological age and sex as confounders. Statistical
analyses were done using the software packages
Statgraphics (Statpoint Technologies, Inc., Warrenton, VA)
and SPSS Statistics 23 (IBM Corp., Armonk, NY, USA).
Statistical significance was assumed at a level of 0.05.
For the different lung function indices and 6MWD the
following reference values were used: Quanjer et al. for
spirometric parameters [1], Koch et al. for plethysmo-
graphic parameters [14], van der Lee et al. for pulmonary
gas exchange [15], Enright et al. for PImax [16], and
Enright & Sherrill for 6MWD [17].
Results
Baseline characteristics
The anthropometric characteristics of the two study
groups are given in Table 1. There were no significant
differences between UED and LED subjects regarding
age, height and sex. However, the percentage of former
smokers was higher in the LED group; in former
smokers the number of pack years showed a tendency to
be higher in the LED vs. UED group, but without statis-
tically significant difference. Weight and body mass
index (BMI) were slightly higher in the LED group
(p < 0.01 each). The prevalences of cardiovascular
diseases, diabetes and arthritis were similar; neuro-
logical diseases were only present in 4 subjects of
the LED group.
Spirometry
Data on spirometry are given in Table 2. Corresponding
to the selection criterion for the groups, LED subjects
showed lower mean FEV1 and FVC (difference of
predicted values between groups Δ = 39.4%pred and
Δ = 25.4%pred, respectively; p < 0.001 each) as well as
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a lower FEV1/FVC ratio (Δ = 10.7%). If the LLN criterion
for FEV1/FVC [18] was applied, 37.3% of subjects from
the LED group showed airflow limitation, in the absence of
respiratory symptoms or a history of respiratory disease.
Body plethysmography
sGaw and Gaw in terms of %predicted were different
between both groups (p < 0.001 each; Table 3). In 13.8% of
subjects (31.4% LED, 1.4% UED) sGaw was below the 5th
percentile [14]. TLCpleth was lower (Δ = 10.9%pred) in
LED subjects (p < 0.001), whereas no significant differ-
ences occurred for RV and ITGV. RV/TLCpleth and ITGV/
TLCpleth were higher (Δ = 14.0%pred and Δ = 10.3%pred,
respectively; p < 0.001 each) in the LED group (Table 3).
CO and NO uptake of the lung
The transfer factors TLCO (p < 0.001), TLNO (p < 0.001)
and the ratio TLNO/TLCO (p < 0.001) were lower in the
LED group, whereas no significant differences occurred
for the transfer coefficients TLCO/VA (KCO) and TLNO/
VA (KNO) (Table 4). There were also significant differ-
ences regarding the ratio TLCHe/TLCpleth with higher
values in the UED subjects (p < 0.05). Haemoglobin levels
for which CO transfer factors were corrected did not sig-
nificantly differ between LED and UED subjects.
Respiratory pump function, 6-min-walk distance and
biomarkers
PImax was lower in LED subjects (Δ = 11.0%pred), while
P01 and P01/PImax were higher (p < 0.001 each; Table 5).
Table 1 Characteristics of the study population
Parameter UED group LED group Mean
difference
(UED-LED)
95% CI of difference p-value
for differenceMean ± SD Median (25%; 75%) Mean ± SD Median (25%; 75%) Lower Upper
Number 72 51 na na na na
Sex, m/f 28 / 44 27 / 24 na na na 0.123a
Age, years 76.8 ± 6.4 76.5 (71.3; 81.9) 77.8 ± 7.2 77.6 (70.6; 83.9) −1.0 −3.5 1,5 0.425
Height, m 1.63 ± 0.09 1.63 (1.56; 1.70) 1.64 ± 0.09 1.64 (1.57; 1.71) −0.00 − 0.04 0.03 0.793
Weight, kg 73.1 ± 10.2 72.9 (65.3; 81.0) 79.6 ± 13.3 78.9 (69.3; 88.6) −6.4 −10.8 −2.0 0.005
BMI, kg/m2 27.5 ± 3.9 27.2 (25.1; 29.5) 29.7 ± 4.4 28.6 (26.9; 32.2) −2.2 −3.7 −0.6 0.006
Former smokers, n (percentage) 21 (29.2%) 26 (51.0%) na na na 0.014a
Pack years in former smokers, years 14.6 ± 17.0 9.4 (1.5; 21.0) 20.5 ± 20.8 12.2 (1.5; 36.6) −5.9 −17.4 5.7 0.592b
Diseases, n (percentage)
Cardiovascular diseases 54 (75.0%) 44 (86.3%) na na na 0.126a
Diabetes 8 (11.3%) 8 (15.7%) na na na 0.476a
Neurological diseases 0 (0.0%) 4 (7.8%) na na na na
Arthritis 5 (6.9%) 8 (15.7%) na na na 0.120a
aChi-Square test, bMann-Whitney U test
p-values below 0.05 are shown in bold
Table 2 Spirometric parameters







Number Mean ± SD Median (25%; 75%) Number Mean ± SD Median (25%; 75%) Lower Upper
FEV1%pred 72 124.9 ± 10.3 124.6 (116.9; 131.4) 51 85.5 ± 10.9 85.1 (77.1; 91.4) 39.4 35.5 43.3 < 0.001
FVC %pred 72 127.2 ± 10.9 129.8 (119.3; 134.4) 51 101.8 ± 13.0 102.0 (95.6; 108.8) 25.4 21.0 29.8 < 0.001
FEV1/FVC %pred 72 97.5 ± 6.2 97.7 (92.7; 102.3) 51 83.9 ± 10.4 84.4 (78.3; 91.0) 13.6 10.4 16.9 < 0.001
FEF25–75%pred 72 124.7 ± 34.8 120.4 (99.3; 148.8) 49 56.1 ± 23.6 49.2 (39.5; 65.0) 69.8 59.3 80.2 < 0.001
FEF75%pred 72 168.0 ± 66.3 159.7 (118.3; 204.9) 49 74.1 ± 39.5 65.5 (49.2; 86.8) 93.9 74.8 113.0 < 0.001
FEV1 z-score 72 1.465 ± 0.587 1.433 (0.991; 1.862) 51 −0.819 ± 0.610 −0.847 (−1.288; −0.527) 2.284 2.068 2.500 < 0.001
FVC z-score 72 1.514 ± 0.579 1.629 (1.124; 1.889) 51 0.101 ± 0.728 0.112 (− 0.270; 0.524) 1.413 1.180 1.647 < 0.001
FEV1/FVC z-score 72 −0.221 ± 0.579 −0.200 (− 0.654; 0.230) 51 −1.389 ± 0.857 −1.349 (− 1.953; − 0.798) 1.168 0.911 1.424 < 0.001
FEF25–75 z-score 72 0.479 ± 0.702 0.451 (− 0.014; 0.990) 49 − 1.229 ± 0.721 −1.343 (− 1.721; − 0.955) 1.709 1.448 1.969 < 0.001
FEF75 z-score 72 0.697 ± 0.614 0.752 (0.274; 1.108) 49 − 0.658 ± 0.750 −0.659 (− 1.147; − 0.241) 1.355 1.109 1.602 < 0.001
FEV1/FVC 72 0.749 ± 0.048 0.752 (0.713; 0.785) 51 0.642 ± 0.079 0.652 (0.595; 0.697) 0.107 0.082 0.132 < 0.001
Reference values were calculated according to Quanjer et al. [1]
p-values below 0.05 are shown in bold
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LED subjects had a lower 6MWD (Δ = 14.1%pred) than
UED subjects (p < 0.001). Moreover, baseline values of
perceived fatigue and dyspnoea during the walk test
were higher in LED subjects (p = 0.001 and p = 0.025,
respectively; Table 5).
No significant differences between both groups were
found for FeNO (Table 5). eCO was slightly higher
(Δ = 0.8 ppm) in LED versus UED subjects (p < 0.001).
For 8-OHdG no significant difference between groups
was observed. The same was true for telomere length
but there was a tendency towards shorter telomeres
in LED subjects (p = 0.058).
Correlation of functional indices with biomarkers
In multiple regression analyses including all subjects, no
significant relationships between lung function indices
and telomere length or 8-OHdG levels were found,
except for a positive association between RV/TLC and
telomere length (p = 0.048).
Discussion
In the present study we compared two subgroups from a
larger population-based cohort which were selected to
show FEV1 either at the lower end (LED) or the upper
end (UED) of the distribution in the whole cohort. These
subgroups were selected to be lung-healthy according to
clinical history, symptoms and risk factors. The broad
set of parameters allowed to compare the two groups
regarding a number of functional domains. Deteriora-
tions in spirometric values are sometimes interpreted as
indicators of premature aging of the lung [2] but it is
not clear whether these reflect a general respiratory
status that would justify the terminology of an individual
(overall) “lung age”. The adequacy of this notion can
only be evaluated by comparison of a broad panel of
lung function parameters, preferentially in a longitudinal
cohort. However, the comparison between parameters
should also be possible in carefully selected individuals
of a cross-sectional analysis. Our study was suited for
such a comparison, as it comprised spirometry, body
plethysmography, transfer factors for CO and NO, and
respiratory pump function. Additionally, telomere length
of peripheral blood leukocytes and 8-OHdG were
included as markers of biological age and stress.
We found a difference of about 40% predicted FEV1
between the LED and UED group. This was the result of
the definition of both groups but nonetheless reflected
the huge difference in FEV1 even among lung-healthy
Table 3 Body plethysmographic parameters







Number Mean ± SD Median (25%; 75%) Number Mean ± SD Median (25%; 75%) Lower Upper
TLCpleth %pred 72 113.2 ± 11.9 115.9 (104.8; 122.2) 51 102.3 ± 12.4 102.6 (94.4; 112.2) 10.9 6.5 15.4 < 0.001
RV %pred 72 94.4 ± 16.7 96.6 (82.9; 103.5) 51 99.7 ± 18.5 102.5 (92.1; 110.5) −5.3 −11.8 1.1 0.104
RV/TLCpleth %pred 72 84.9 ± 9.4 85.2 (78.1; 91.7) 51 98.9 ± 11.9 98.0 (91.2; 108.0) −14.0 − 18.0 − 10.0 < 0.001
ITGV %pred 72 99.7 ± 18.8 100.4 (85.8; 110.2) 51 101.3 ± 19.5 101.1 (86.2; 118.0) −1.6 −8.5 5.4 0.656
ITGV/TLCpleth %pred 72 83.8 ± 9.0 83.1 (76.8; 89.9) 51 94.1 ± 10.4 93.8 (86.9; 102.1) −10.3 − 13.9 −6.7 < 0.001
GAW %pred 72 125.7 ± 40.1 121.0 (97.8; 145.3) 51 77.2 ± 36.1 70.2 (52.0; 97.6) 48.6 34.8 62.3 < 0.001
sGAW %pred 72 138.4 ± 42.1 134.6 (112.8; 153.2) 51 88.3 ± 47.7 84.2 (62.3; 107.7) 50.0 33.5 66.5 < 0.001
Reference values were calculated according to Koch et al. [14]
p-values below 0.05 are shown in bold
Table 4 Parameters of the diffusing capacity for CO and NO







Number Mean ± SD Median (25%; 75%) Number Mean ± SD Median (25%; 75%) Lower Upper
TLCO %pred 70 92.1 ± 16.7 89.8 (81.3; 102.2) 51 82.2 ± 14.2 83.2 (68.4; 92.9) 9.8 4.3 15.4 0.001
KCO %pred 70 98.6 ± 16.7 98.7 (89.0; 110.3) 51 101.8 ± 17.7 100.1 (89.3; 112.1) −3.2 −9.5 3.1 0.316
TLNO %pred 70 95.0 ± 17.4 94.1 (83.8; 106.2) 51 80.0 ± 14.8 79.6 (70.1; 92.1) 15.0 9.2 20.8 < 0.001
KNO %pred 70 102.7 ± 17.8 102.5 (93.3; 113.9) 51 100.0 ± 16.5 101.1 (87.4; 108.5) 2.7 −3.6 8.9 0.400
TLNO/TLCO 70 4.74 ± 0.34 4.67 (4.54; 4.92) 51 4.53 ± 0.29 4.52 (4.36; 4.65) 0.21 0.10 0.33 < 0.001
TLCHe/TLCpleth 70 0.834 ± 0.052 0.832 (0.798; 0.867) 51 0.806 ± 0.071 0.810 (0.755; 0.851) 0.028 0.005 0.052 0.018
Hb, mg/dl 53 13.9 ± 1.1 13.9 (13.2; 14.8) 48 13.7 ± 1.3 13.7 (12.8; 14.5) 0.2 −0.3 0.7 0.469
Reference values were calculated according to van der Lee et al. [15]
p-values below 0.05 are shown in bold
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elderly subjects. The differences in FVC and in FEV1/
FVC were smaller. On the other hand, those of the FEFs
as well as airway conductance and specific airway con-
ductance were even larger. The scales of these parame-
ters were comparable with each other, since airway
conductance was chosen instead of resistance and
impairment was always associated with a reduction towards
zero. The comparison with the differences in plethysmo-
graphic volume parameters was less straightforward, since
in principle, although not in practice, there is no upper
bound of these parameters and no commonly accepted
transformation analogous to conductance. Based on the
differences in scale and physiologically possible range, it is
understandable that the volume parameters showed smaller
differences between the two groups.
In contrast, NO and CO transfer factors also decrease
upon impairment, having zero as lower bound, and are
in this respect comparable to the spirometric and airway
conductance parameters. Despite this similarity the
differences between LED and UED groups were only
about 10% in case of TLCO and about 15% in case of
TLNO. Both of these parameters involve lung volume,
therefore the transfer coefficients which in first order
correct for volume are of particular interest, as CO
diffusing capacity is sensitive to changes pulmonary ca-
pillary blood volume and NO diffusing capacity to those
of the diffusion barrier. Both are likely to be affected by
aging processes, thus a general aging of the lung should
also have effects.
Remarkably, however, the differences in KCO and
KNO between the two groups were small and not
significantly different from zero indicating that the
differences in transfer factors were primarily due to
differences in volume, i.e. of lung-mechanical nature.
KCO values were also similar when using the reference
values by Garcia-Rio et al. [19] for KCO (84.4%pred in
UED vs. 82.9%pred in LED subjects). Moreover, the
95%-confidence intervals for the differences in transfer
factors and coefficients did not overlap with those of
FEV1%pred and FVC%pred as well as airway conductance.
There were no significant differences in Hb values which
might have influenced the values of the CO transfer factor
despite the correction for Hb. The differences in PImax
they were lower than those of FEV1 and sGAW, which
showed values in a range of 30%pred or more, but still
beyond 10%pred and larger than those of transfer coeffi-
cients KCO and KNO. Overall, these observations indicated
a marked difference between the lung-mechanical and gas
uptake domains. Regarding the concept of a general “lung
age” our observations suggest that a differentiated descrip-
tion of functional domains is more adequate.
The difference in 6MWD between the LED and UED
group was between those of mechanical and gas
exchange parameters. Dyspnoea and fatigue scores could
not be scaled as percent predicted, therefore their differ-
ences were not directly comparable to the other parame-
ters. Still, the fact that they differed between the two
groups, in terms of pre and post values, indicated a
greater 6MWD and at the same time lower dyspnoea
and fatigue in subjects of the UED group.
FeNO was included as it might indicate eosinophilic
airway inflammation if elevated, or oxidative stress if
decreased, but no significant differences were found.
There was a small difference regarding eCO despite the
fact that we had excluded current smokers and subjects
with values > 6 ppm. The source of this small difference
might be unreported active or passive smoking, or
endogenous production related to oxidative stress [20].
Table 5 Parameters of respiratory pump function, exercise capacity and biomarkers







Number Mean ± SD Median (25%; 75%) Number Mean ± SD Median (25%; 75%) lower upper
PImax %pred 66 102.9 ± 34.0 100.7 (81.5; 123.2) 50 91.9 ± 31.9 90.9 (70.4; 111.0) 11.0 −1.3 23.3 0.079
log10(P01, kPa) 66 −0.72 ± 0.22 − 0.69 (− 0.89; − 0.55) 50 −0,53 ± 0,20 −0.53 (− 0.64; − 0.41) −0.19 − 0.27 −0.11 < 0.001
log10(P01/PImax) 66 −1.57 ± 0.27 −1.52 (− 1.74; − 1.41) 50 −1.34 ± 0.30 −1.34 (− 1.54; − 1.12) − 0.22 − 0.33 − 0.12 < 0.001
6MWD %pred 71 113.0 ± 17.9 114.2 (98.8; 126.1) 51 98.9 ± 21.1 101.4 (91.1; 112.4) 14.1 6.9 21.4 < 0.001
PRE Dyspnoea 60 0.06 ± 0.21 0.00 (0.00; 0.00) 49 0.51 ± 0.92 0.00 (0.00; 1.00) − 0.45 −0.72 − 0.18 0.001
POST Dyspnoea 60 1.63 ± 1.51 1.00 (0.50; 3.00) 49 2.62 ± 1.78 3.00 (1.00; 4.00) −1.00 − 1.63 −0.36 0.002
PRE Fatigue 60 0.26 ± 0.61 0.00 (0.00; 0.00) 49 0.62 ± 0.97 0.00 (0.00; 1.00) −0.36 −0.68 − 0.05 0.025
POST Fatigue 60 0.61 ± 1.20 0.00 (0.00; 0.88) 49 1.09 ± 1.30 0.50 (0.00; 2.00) −0.48 −0.96 − 0.01 0.048
eCO, ppm 72 3.5 ± 1.3 3.0 (3.0; 4.0) 51 4.4 ± 1.2 4.0 (3.0; 5.0) −0.8 −1.3 −0.4 < 0.001
log10(FeNO, ppb) 72 1.305 ± 0.164 1.306 (1.206; 1.422) 51 1.334 ± 0.222 1.317 (1.179; 1.508) −0.029 −0.102 0.044 0.433
serum 8-OHdG, ng/mL 72 0.181 ± 0.065 0.186 (0.129; 0.228) 50 0.178 ± 0.065 0.180 (0.144; 0.212) 0.002 −0.022 0.026 0.845
Telomere length, T/S ratio 72 1.562 ± 0.244 1.564 (1.412; 1.699) 50 1.489 ± 0.179 1.472 (1.344; 1.609) 0.073 −0.003 0.149 0.058
Reference values were calculated according to Enright et al. [16] for PImax and according to Enright and Sherrill [17] for 6MWD
p-values below 0.05 are shown in bold
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However, serum 8-OHdG, as an indicator of systemic
oxidative stress, was similar in the two groups. The same
was true for telomere length in peripheral blood leuko-
cytes which is often considered as a marker of biological
age and/or stress but there was a tendency (p = 0.058)
towards decreased telomere length in the LED group.
One might argue that the results in terms of percent
predicted values simply reflected different coefficients of
age-dependence in the reference equations despite the
fact that the mean age was similar in the two groups. To
evaluate this we inserted the measured values into the
respective reference equations and solved for the age that
resulted in the observed values; for non-linear equations
(e.g. GLI) linear approximations within the adequate
range were used. This analysis was not meaningful for all
parameters as it made sense only with an obvious and
monotonous relationship to age to avoid absurd individ-
ual age estimates. Figure 1 shows median values and
quartiles for FEV1, FVC, FEF25–75, FEF75, ITGV/TLC,
KCO and KNO. It illustrates the large differences for
mechanical versus much smaller differences for gas up-
take parameters, taking into account the coefficients of
age-dependence via the prediction equations.
As one of the limitations of our study, we did not meas-
ure individual rates of ageing. Still, the cross-sectional ana-
lysis used by us allowed for the comparison of different
functional domains. Naturally, it is not possible to decide
whether the differences between the two groups existed
from the beginning, i.e. from young age, or whether they
developed over time [21], e.g. due to environmental factors
and cigarette smoke exposure. Therefore, an interpretation
of our data in terms of “aging” or “premature aging” is not
straightforward, since even telomere length might also have
been shorter from the beginning. This objection does, how-
ever, not compromise the aim of our study which was the
analysis of the notion “lung age” that is commonly derived
from spirometry alone. The sample size of n = 123 did not
allow to adjust for a broad variety of potential confounders;
we therefore present only pairwise comparisons. Adjust-
ment for weight or sex did not markedly change the results.
Furthermore, it was not possible to directly compare all
parameters, either because no reference values were
available, or because, e.g. for ITGV, pathological changes
can occur in both directions and scales were different. Our
study has the strength of a broad panel of high-quality
assessments that allowed direct comparisons in the same
subjects. This aspect seems particularly important in view
of the marked differences between the functional domains.
Conclusions
Two groups of elderly, lung-healthy subjects were
chosen from the lower and upper end of the distribution
of FEV1%predicted from a population-based sample. The
differences of lung function parameters between groups
depended on the functional domain. While those of
FEV1, FVC and (specific) airway conductance were large,
Fig. 1 Median “functional age” of UED (white) and LED (grey) subjects for selected parameters; whiskers indicate lower and upper quartiles, the
dashed black line indicates the mean chronological age of all subjects. Please note that lower “functional age” is associated with, for example,
higher values of FEV1%pred
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those of KCO and KNO transfer coefficients were small
and not significantly different from zero. Therefore, the
differences in lung-mechanics associated with the selec-
tion of the two groups were not in parallel with those in
gas uptake. Using the respective prediction equation, a
“functional age” is often computed for FEV1, especially
for pedagogical purposes. When adopting this approach
for other parameters, the differences between groups
translated into corresponding differences in the “func-
tional ages”. This again underlined that the notion of a
unique “lung age” is ill-founded, at least when referring
to functional indices, and a differentiated description
should be preferred.
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